Global Rare Kidney Diseases Treatment Market Report, History and Forecast 2018-2029, Breakdown Data by Companies, Key Regions, Types and Application

• Description
• Table of Contents
• Table of Figures
• PDF Download

• Description
• Table of Contents
• Table of Figures
• PDF Download

Global Rare Kidney Diseases Treatment market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Demand from Atypical Hemolytic Uremic Syndrome and Nephropathic Cystinosis are the major drivers for the industry.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Rare Kidney Diseases Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Companies, Type, Application and Regions Listed in the Report:
By Company
    Aurinia Pharmaceuticals
    Sanofi
    Calliditas Therapeutics AB
    Shire
    GSK
    Amicus Therapeutics
    Horizon Therapeutics
    Advicenne
    Reata Pharmaceuticals
    Alexion Pharmaceuticals
    Otsuka Pharmaceutical

Segment by Type
    Enzyme Replacement Therapy
    Monoclonal Antibodies
    Others

Segment by Application
    Atypical Hemolytic Uremic Syndrome
    Nephropathic Cystinosis
    Lupus Nephritis
    Others

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        
    Latin America
        Mexico
        Brazil
        
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

Each chapter of the report provides detailed information for readers to understand the Rare Kidney Diseases Treatment market further:
Chapter 1: Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029).
Chapter 2: Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3: Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4: Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Companies’ Outline, covering company’s basic information, Rare Kidney Diseases Treatment introduction, etc. Rare Kidney Diseases Treatment Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10: Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11: Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12: QYResearch’s Conclusions of Rare Kidney Diseases Treatment market based on comprehensive survey.
Chapter 13: Methodology and Data Sources adopted by QYResearch.

 1 Market Overview of Rare Kidney Diseases Treatment
    1.1 Rare Kidney Diseases Treatment Market Overview
        1.1.1 Rare Kidney Diseases Treatment Product Scope
        1.1.2 Rare Kidney Diseases Treatment Market Status and Outlook
    1.2 Global Rare Kidney Diseases Treatment Market Size Overview by Region 2018 VS 2022 VS 2029
    1.3 Global Rare Kidney Diseases Treatment Market Size by Region (2018-2029)
    1.4 Global Rare Kidney Diseases Treatment Historic Market Size by Region (2018-2023)
    1.5 Global Rare Kidney Diseases Treatment Market Size Forecast by Region (2024-2029)
    1.6 Key Regions, Rare Kidney Diseases Treatment Market Size (2018-2029)
        1.6.1 North America Rare Kidney Diseases Treatment Market Size (2018-2029)
        1.6.2 Europe Rare Kidney Diseases Treatment Market Size (2018-2029)
        1.6.3 Asia-Pacific Rare Kidney Diseases Treatment Market Size (2018-2029)
        1.6.4 Latin America Rare Kidney Diseases Treatment Market Size (2018-2029)
        1.6.5 Middle East & Africa Rare Kidney Diseases Treatment Market Size (2018-2029)

 2 Rare Kidney Diseases Treatment Market by Type
    2.1 Introduction
        2.1.1 Enzyme Replacement Therapy
        2.1.2 Monoclonal Antibodies
        2.1.3 Others
    2.2 Global Rare Kidney Diseases Treatment Market Size by Type: 2018 VS 2022 VS 2029
        2.2.1 Global Rare Kidney Diseases Treatment Historic Market Size by Type (2018-2023)
        2.2.2 Global Rare Kidney Diseases Treatment Forecasted Market Size by Type (2024-2029)
    2.3 Key Regions Market Size by Type
        2.3.1 North America Rare Kidney Diseases Treatment Revenue Breakdown by Type (2018-2029)
        2.3.2 Europe Rare Kidney Diseases Treatment Revenue Breakdown by Type (2018-2029)
        2.3.3 Asia-Pacific Rare Kidney Diseases Treatment Revenue Breakdown by Type (2018-2029)
        2.3.4 Latin America Rare Kidney Diseases Treatment Revenue Breakdown by Type (2018-2029)
        2.3.5 Middle East and Africa Rare Kidney Diseases Treatment Revenue Breakdown by Type (2018-2029)

 3 Rare Kidney Diseases Treatment Market Overview by Application
    3.1 Introduction
        3.1.1 Atypical Hemolytic Uremic Syndrome
        3.1.2 Nephropathic Cystinosis
        3.1.3 Lupus Nephritis
        3.1.4 Others
    3.2 Global Rare Kidney Diseases Treatment Market Size by Application: 2018 VS 2022 VS 2029
        3.2.1 Global Rare Kidney Diseases Treatment Historic Market Size by Application (2018-2023)
        3.2.2 Global Rare Kidney Diseases Treatment Forecasted Market Size by Application (2024-2029)
    3.3 Key Regions Market Size by Application
        3.3.1 North America Rare Kidney Diseases Treatment Revenue Breakdown by Application (2018-2029)
        3.3.2 Europe Rare Kidney Diseases Treatment Revenue Breakdown by Application (2018-2029)
        3.3.3 Asia-Pacific Rare Kidney Diseases Treatment Revenue Breakdown by Application (2018-2029)
        3.3.4 Latin America Rare Kidney Diseases Treatment Revenue Breakdown by Application (2018-2029)
        3.3.5 Middle East and Africa Rare Kidney Diseases Treatment Revenue Breakdown by Application (2018-2029)

 4 Rare Kidney Diseases Treatment Competition Analysis by Players
    4.1 Global Rare Kidney Diseases Treatment Market Size by Players (2018-2023)
    4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Rare Kidney Diseases Treatment as of 2022)
    4.3 Date of Key Players Enter into Rare Kidney Diseases Treatment Market
    4.4 Global Top Players Rare Kidney Diseases Treatment Headquarters and Area Served
    4.5 Key Players Rare Kidney Diseases Treatment Product Solution and Service
    4.6 Competitive Status
        4.6.1 Rare Kidney Diseases Treatment Market Concentration Rate
        4.6.2 Mergers & Acquisitions, Expansion Plans

 5 Company (Top Players) Profiles
    5.1 Aurinia Pharmaceuticals
        5.1.1 Aurinia Pharmaceuticals Profile
        5.1.2 Aurinia Pharmaceuticals Main Business
        5.1.3 Aurinia Pharmaceuticals Rare Kidney Diseases Treatment Products, Services and Solutions
        5.1.4 Aurinia Pharmaceuticals Rare Kidney Diseases Treatment Revenue (US$ Million) & (2018-2023)
        5.1.5 Aurinia Pharmaceuticals Recent Developments
    5.2 Sanofi
        5.2.1 Sanofi Profile
        5.2.2 Sanofi Main Business
        5.2.3 Sanofi Rare Kidney Diseases Treatment Products, Services and Solutions
        5.2.4 Sanofi Rare Kidney Diseases Treatment Revenue (US$ Million) & (2018-2023)
        5.2.5 Sanofi Recent Developments
    5.3 Calliditas Therapeutics AB
        5.3.1 Calliditas Therapeutics AB Profile
        5.3.2 Calliditas Therapeutics AB Main Business
        5.3.3 Calliditas Therapeutics AB Rare Kidney Diseases Treatment Products, Services and Solutions
        5.3.4 Calliditas Therapeutics AB Rare Kidney Diseases Treatment Revenue (US$ Million) & (2018-2023)
        5.3.5 Shire Recent Developments
    5.4 Shire
        5.4.1 Shire Profile
        5.4.2 Shire Main Business
        5.4.3 Shire Rare Kidney Diseases Treatment Products, Services and Solutions
        5.4.4 Shire Rare Kidney Diseases Treatment Revenue (US$ Million) & (2018-2023)
        5.4.5 Shire Recent Developments
    5.5 GSK
        5.5.1 GSK Profile
        5.5.2 GSK Main Business
        5.5.3 GSK Rare Kidney Diseases Treatment Products, Services and Solutions
        5.5.4 GSK Rare Kidney Diseases Treatment Revenue (US$ Million) & (2018-2023)
        5.5.5 GSK Recent Developments
    5.6 Amicus Therapeutics
        5.6.1 Amicus Therapeutics Profile
        5.6.2 Amicus Therapeutics Main Business
        5.6.3 Amicus Therapeutics Rare Kidney Diseases Treatment Products, Services and Solutions
        5.6.4 Amicus Therapeutics Rare Kidney Diseases Treatment Revenue (US$ Million) & (2018-2023)
        5.6.5 Amicus Therapeutics Recent Developments
    5.7 Horizon Therapeutics
        5.7.1 Horizon Therapeutics Profile
        5.7.2 Horizon Therapeutics Main Business
        5.7.3 Horizon Therapeutics Rare Kidney Diseases Treatment Products, Services and Solutions
        5.7.4 Horizon Therapeutics Rare Kidney Diseases Treatment Revenue (US$ Million) & (2018-2023)
        5.7.5 Horizon Therapeutics Recent Developments
    5.8 Advicenne
        5.8.1 Advicenne Profile
        5.8.2 Advicenne Main Business
        5.8.3 Advicenne Rare Kidney Diseases Treatment Products, Services and Solutions
        5.8.4 Advicenne Rare Kidney Diseases Treatment Revenue (US$ Million) & (2018-2023)
        5.8.5 Advicenne Recent Developments
    5.9 Reata Pharmaceuticals
        5.9.1 Reata Pharmaceuticals Profile
        5.9.2 Reata Pharmaceuticals Main Business
        5.9.3 Reata Pharmaceuticals Rare Kidney Diseases Treatment Products, Services and Solutions
        5.9.4 Reata Pharmaceuticals Rare Kidney Diseases Treatment Revenue (US$ Million) & (2018-2023)
        5.9.5 Reata Pharmaceuticals Recent Developments
    5.10 Alexion Pharmaceuticals
        5.10.1 Alexion Pharmaceuticals Profile
        5.10.2 Alexion Pharmaceuticals Main Business
        5.10.3 Alexion Pharmaceuticals Rare Kidney Diseases Treatment Products, Services and Solutions
        5.10.4 Alexion Pharmaceuticals Rare Kidney Diseases Treatment Revenue (US$ Million) & (2018-2023)
        5.10.5 Alexion Pharmaceuticals Recent Developments
    5.11 Otsuka Pharmaceutical
        5.11.1 Otsuka Pharmaceutical Profile
        5.11.2 Otsuka Pharmaceutical Main Business
        5.11.3 Otsuka Pharmaceutical Rare Kidney Diseases Treatment Products, Services and Solutions
        5.11.4 Otsuka Pharmaceutical Rare Kidney Diseases Treatment Revenue (US$ Million) & (2018-2023)
        5.11.5 Otsuka Pharmaceutical Recent Developments

 6 North America
    6.1 North America Rare Kidney Diseases Treatment Market Size by Country (2018-2029)
    6.2 United States
    6.3 Canada

 7 Europe
    7.1 Europe Rare Kidney Diseases Treatment Market Size by Country (2018-2029)
    7.2 Germany
    7.3 France
    7.4 U.K.
    7.5 Italy
    7.6 Russia
    7.7 Nordic Countries
    7.8 Rest of Europe

 8 Asia-Pacific
    8.1 Asia-Pacific Rare Kidney Diseases Treatment Market Size by Region (2018-2029)
    8.2 China
    8.3 Japan
    8.4 South Korea
    8.5 Southeast Asia
    8.6 India
    8.7 Australia
    8.8 Rest of Asia-Pacific

 9 Latin America
    9.1 Latin America Rare Kidney Diseases Treatment Market Size by Country (2018-2029)
    9.2 Mexico
    9.3 Brazil
    9.4 Rest of Latin America

 10 Middle East & Africa
    10.1 Middle East & Africa Rare Kidney Diseases Treatment Market Size by Country (2018-2029)
    10.2 Turkey
    10.3 Saudi Arabia
    10.4 UAE
    10.5 Rest of Middle East & Africa

 11 Rare Kidney Diseases Treatment Market Dynamics
    11.1 Rare Kidney Diseases Treatment Industry Trends
    11.2 Rare Kidney Diseases Treatment Market Drivers
    11.3 Rare Kidney Diseases Treatment Market Challenges
    11.4 Rare Kidney Diseases Treatment Market Restraints

 12 Research Finding /Conclusion

 13 Methodology and Data Source
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer

List of Tables
    Table 1. Global Market Rare Kidney Diseases Treatment Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
    Table 2. Global Rare Kidney Diseases Treatment Market Size by Region (2018-2023) & (US$ Million)
    Table 3. Global Rare Kidney Diseases Treatment Market Size Share by Region (2018-2023)
    Table 4. Global Rare Kidney Diseases Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 5. Global Rare Kidney Diseases Treatment Forecasted Market Size Share by Region (2024-2029)
    Table 6. Global Rare Kidney Diseases Treatment Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
    Table 7. Global Rare Kidney Diseases Treatment Market Size by Type (2018-2023) & (US$ Million)
    Table 8. Global Rare Kidney Diseases Treatment Revenue Market Share by Type (2018-2023)
    Table 9. Global Rare Kidney Diseases Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 10. Global Rare Kidney Diseases Treatment Revenue Market Share by Type (2024-2029)
    Table 11. North America Rare Kidney Diseases Treatment Revenue by Type (2018-2023) & (US$ Million)
    Table 12. North America Rare Kidney Diseases Treatment Revenue by Type (2024-2029) & (US$ Million)
    Table 13. Europe Rare Kidney Diseases Treatment Revenue by Type (2018-2023) & (US$ Million)
    Table 14. Europe Rare Kidney Diseases Treatment Revenue by Type (2024-2029) & (US$ Million)
    Table 15. Asia-Pacific Rare Kidney Diseases Treatment Revenue by Type (2018-2023) & (US$ Million)
    Table 16. Asia-Pacific Rare Kidney Diseases Treatment Revenue by Type (2024-2029) & (US$ Million)
    Table 17. Latin America Rare Kidney Diseases Treatment Revenue by Type (2018-2023) & (US$ Million)
    Table 18. Latin America Rare Kidney Diseases Treatment Revenue by Type (2024-2029) & (US$ Million)
    Table 19. Middle East and Africa Rare Kidney Diseases Treatment Revenue by Type (2018-2023) & (US$ Million)
    Table 20. Middle East and Africa Rare Kidney Diseases Treatment Revenue by Type (2024-2029) & (US$ Million)
    Table 21. Global Rare Kidney Diseases Treatment Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
    Table 22. Global Rare Kidney Diseases Treatment Market Size by Application (2018-2023) & (US$ Million)
    Table 23. Global Rare Kidney Diseases Treatment Revenue Market Share by Application (2018-2023)
    Table 24. Global Rare Kidney Diseases Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 25. Global Rare Kidney Diseases Treatment Revenue Market Share by Application (2024-2029)
    Table 26. North America Rare Kidney Diseases Treatment Revenue by Application (2018-2023) & (US$ Million)
    Table 27. North America Rare Kidney Diseases Treatment Revenue by Application (2024-2029) & (US$ Million)
    Table 28. Europe Rare Kidney Diseases Treatment Revenue by Application (2018-2023) & (US$ Million)
    Table 29. Europe Rare Kidney Diseases Treatment Revenue by Application (2024-2029) & (US$ Million)
    Table 30. Asia-Pacific Rare Kidney Diseases Treatment Revenue by Application (2018-2023) & (US$ Million)
    Table 31. Asia-Pacific Rare Kidney Diseases Treatment Revenue by Application (2024-2029) & (US$ Million)
    Table 32. Latin America Rare Kidney Diseases Treatment Revenue by Application (2018-2023) & (US$ Million)
    Table 33. Latin America Rare Kidney Diseases Treatment Revenue by Application (2024-2029) & (US$ Million)
    Table 34. Middle East and Africa Rare Kidney Diseases Treatment Revenue by Application (2018-2023) & (US$ Million)
    Table 35. Middle East and Africa Rare Kidney Diseases Treatment Revenue by Application (2024-2029) & (US$ Million)
    Table 36. Global Rare Kidney Diseases Treatment Revenue (US$ Million) by Players (2018-2023)
    Table 37. Global Rare Kidney Diseases Treatment Revenue Market Share by Players (2018-2023)
    Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Rare Kidney Diseases Treatment as of 2022)
    Table 39. Date of Key Players Enter into Rare Kidney Diseases Treatment Market
    Table 40. Global Rare Kidney Diseases Treatment Key Players Headquarters and Area Served
    Table 41. Rare Kidney Diseases Treatment Product Solution and Service
    Table 42. Global Rare Kidney Diseases Treatment Players Market Concentration Ratio (CR5 and HHI)
    Table 43. Mergers & Acquisitions, Expansion Plans
    Table 44. Aurinia Pharmaceuticals Basic Information List
    Table 45. Aurinia Pharmaceuticals Description and Business Overview
    Table 46. Aurinia Pharmaceuticals Rare Kidney Diseases Treatment Products, Services and Solutions
    Table 47. Revenue (US$ Million) in Rare Kidney Diseases Treatment Business of Aurinia Pharmaceuticals (2018-2023)
    Table 48. Aurinia Pharmaceuticals Recent Developments
    Table 49. Sanofi Basic Information List
    Table 50. Sanofi Description and Business Overview
    Table 51. Sanofi Rare Kidney Diseases Treatment Products, Services and Solutions
    Table 52. Revenue (US$ Million) in Rare Kidney Diseases Treatment Business of Sanofi (2018-2023)
    Table 53. Sanofi Recent Developments
    Table 54. Calliditas Therapeutics AB Basic Information List
    Table 55. Calliditas Therapeutics AB Description and Business Overview
    Table 56. Calliditas Therapeutics AB Rare Kidney Diseases Treatment Products, Services and Solutions
    Table 57. Revenue (US$ Million) in Rare Kidney Diseases Treatment Business of Calliditas Therapeutics AB (2018-2023)
    Table 58. Calliditas Therapeutics AB Recent Developments
    Table 59. Shire Basic Information List
    Table 60. Shire Description and Business Overview
    Table 61. Shire Rare Kidney Diseases Treatment Products, Services and Solutions
    Table 62. Revenue (US$ Million) in Rare Kidney Diseases Treatment Business of Shire (2018-2023)
    Table 63. Shire Recent Developments
    Table 64. GSK Basic Information List
    Table 65. GSK Description and Business Overview
    Table 66. GSK Rare Kidney Diseases Treatment Products, Services and Solutions
    Table 67. Revenue (US$ Million) in Rare Kidney Diseases Treatment Business of GSK (2018-2023)
    Table 68. GSK Recent Developments
    Table 69. Amicus Therapeutics Basic Information List
    Table 70. Amicus Therapeutics Description and Business Overview
    Table 71. Amicus Therapeutics Rare Kidney Diseases Treatment Products, Services and Solutions
    Table 72. Revenue (US$ Million) in Rare Kidney Diseases Treatment Business of Amicus Therapeutics (2018-2023)
    Table 73. Amicus Therapeutics Recent Developments
    Table 74. Horizon Therapeutics Basic Information List
    Table 75. Horizon Therapeutics Description and Business Overview
    Table 76. Horizon Therapeutics Rare Kidney Diseases Treatment Products, Services and Solutions
    Table 77. Revenue (US$ Million) in Rare Kidney Diseases Treatment Business of Horizon Therapeutics (2018-2023)
    Table 78. Horizon Therapeutics Recent Developments
    Table 79. Advicenne Basic Information List
    Table 80. Advicenne Description and Business Overview
    Table 81. Advicenne Rare Kidney Diseases Treatment Products, Services and Solutions
    Table 82. Revenue (US$ Million) in Rare Kidney Diseases Treatment Business of Advicenne (2018-2023)
    Table 83. Advicenne Recent Developments
    Table 84. Reata Pharmaceuticals Basic Information List
    Table 85. Reata Pharmaceuticals Description and Business Overview
    Table 86. Reata Pharmaceuticals Rare Kidney Diseases Treatment Products, Services and Solutions
    Table 87. Revenue (US$ Million) in Rare Kidney Diseases Treatment Business of Reata Pharmaceuticals (2018-2023)
    Table 88. Reata Pharmaceuticals Recent Developments
    Table 89. Alexion Pharmaceuticals Basic Information List
    Table 90. Alexion Pharmaceuticals Description and Business Overview
    Table 91. Alexion Pharmaceuticals Rare Kidney Diseases Treatment Products, Services and Solutions
    Table 92. Revenue (US$ Million) in Rare Kidney Diseases Treatment Business of Alexion Pharmaceuticals (2018-2023)
    Table 93. Alexion Pharmaceuticals Recent Developments
    Table 94. Otsuka Pharmaceutical Basic Information List
    Table 95. Otsuka Pharmaceutical Description and Business Overview
    Table 96. Otsuka Pharmaceutical Rare Kidney Diseases Treatment Products, Services and Solutions
    Table 97. Revenue (US$ Million) in Rare Kidney Diseases Treatment Business of Otsuka Pharmaceutical (2018-2023)
    Table 98. Otsuka Pharmaceutical Recent Developments
    Table 99. North America Rare Kidney Diseases Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 100. North America Rare Kidney Diseases Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 101. Europe Rare Kidney Diseases Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 102. Europe Rare Kidney Diseases Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 103. Asia-Pacific Rare Kidney Diseases Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 104. Asia-Pacific Rare Kidney Diseases Treatment Market Size by Region (2018-2023) & (US$ Million)
    Table 105. Asia-Pacific Rare Kidney Diseases Treatment Market Size by Region (2024-2029) & (US$ Million)
    Table 106. Asia-Pacific Rare Kidney Diseases Treatment Market Share by Region (2018-2023)
    Table 107. Asia-Pacific Rare Kidney Diseases Treatment Market Share by Region (2024-2029)
    Table 108. Latin America Rare Kidney Diseases Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 109. Latin America Rare Kidney Diseases Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 110. Latin America Rare Kidney Diseases Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 111. Middle East & Africa Rare Kidney Diseases Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 112. Middle East & Africa Rare Kidney Diseases Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 113. Middle East & Africa Rare Kidney Diseases Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 114. Rare Kidney Diseases Treatment Market Trends
    Table 115. Rare Kidney Diseases Treatment Market Drivers
    Table 116. Rare Kidney Diseases Treatment Market Challenges
    Table 117. Rare Kidney Diseases Treatment Market Restraints
    Table 118. Research Programs/Design for This Report
    Table 119. Key Data Information from Secondary Sources
    Table 120. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Rare Kidney Diseases Treatment Market Size Year-over-Year 2018-2029 & (US$ Million)
    Figure 2. Global Rare Kidney Diseases Treatment Market Size (US$ Million), 2018 VS 2022 VS 2029
    Figure 3. Global Rare Kidney Diseases Treatment Market Share by Regions: 2022 VS 2029
    Figure 4. Global Rare Kidney Diseases Treatment Forecasted Market Size Share by Region (2024-2029)
    Figure 5. North America Rare Kidney Diseases Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 6. Europe Rare Kidney Diseases Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 7. Asia-Pacific Rare Kidney Diseases Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 8. Latin America Rare Kidney Diseases Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 9. Middle East & Africa Rare Kidney Diseases Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 10. Product Picture of Enzyme Replacement Therapy
    Figure 11. Global Enzyme Replacement Therapy Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 12. Product Picture of Monoclonal Antibodies
    Figure 13. Global Monoclonal Antibodies Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 14. Product Picture of Others
    Figure 15. Global Others Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 16. Global Rare Kidney Diseases Treatment Market Size Share by Type:  2022 & 2029
    Figure 17. North America Rare Kidney Diseases Treatment Revenue Market Share by Type (2018-2029)
    Figure 18. Europe Rare Kidney Diseases Treatment Revenue Market Share by Type (2018-2029)
    Figure 19. Asia-Pacific Rare Kidney Diseases Treatment Revenue Market Share by Type (2018-2029)
    Figure 20. Latin America Rare Kidney Diseases Treatment Revenue Market Share by Type (2018-2029)
    Figure 21. Middle East and Africa Rare Kidney Diseases Treatment Revenue Market Share by Type (2018-2029)
    Figure 22. Atypical Hemolytic Uremic Syndrome Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 23. Nephropathic Cystinosis Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 24. Lupus Nephritis Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 25. Others Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 26. Global Rare Kidney Diseases Treatment Market Size Share by Application: 2022 & 2029
    Figure 27. North America Rare Kidney Diseases Treatment Revenue Market Share by Application (2018-2029)
    Figure 28. Europe Rare Kidney Diseases Treatment Revenue Market Share by Application (2018-2029)
    Figure 29. Asia-Pacific Rare Kidney Diseases Treatment Revenue Market Share by Application (2018-2029)
    Figure 30. Latin America Rare Kidney Diseases Treatment Revenue Market Share by Application (2018-2029)
    Figure 31. Middle East and Africa Rare Kidney Diseases Treatment Revenue Market Share by Application (2018-2029)
    Figure 32. Rare Kidney Diseases Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 33. Global Top 5 and Top 10 Players Rare Kidney Diseases Treatment Market Share in 2022
    Figure 34. North America Rare Kidney Diseases Treatment Market Share by Country (2018-2029)
    Figure 35. United States Rare Kidney Diseases Treatment Market Size (2018-2029) & (US$ Million)
    Figure 36. Canada Rare Kidney Diseases Treatment Market Size (2018-2029) & (US$ Million)
    Figure 37. Germany Rare Kidney Diseases Treatment Market Size (2018-2029) & (US$ Million)
    Figure 38. France Rare Kidney Diseases Treatment Market Size (2018-2029) & (US$ Million)
    Figure 39. U.K. Rare Kidney Diseases Treatment Market Size (2018-2029) & (US$ Million)
    Figure 40. Italy Rare Kidney Diseases Treatment Market Size (2018-2029) & (US$ Million)
    Figure 41. Russia Rare Kidney Diseases Treatment Market Size (2018-2029) & (US$ Million)
    Figure 42. Nordic Countries Rare Kidney Diseases Treatment Market Size (2018-2029) & (US$ Million)
    Figure 43. Asia-Pacific Rare Kidney Diseases Treatment Market Share by Region (2018-2029)
    Figure 44. China Rare Kidney Diseases Treatment Market Size (2018-2029) & (US$ Million)
    Figure 45. Japan Rare Kidney Diseases Treatment Market Size (2018-2029) & (US$ Million)
    Figure 46. South Korea Rare Kidney Diseases Treatment Market Size (2018-2029) & (US$ Million)
    Figure 47. Southeast Asia Rare Kidney Diseases Treatment Market Size (2018-2029) & (US$ Million)
    Figure 48. India Rare Kidney Diseases Treatment Market Size (2018-2029) & (US$ Million)
    Figure 49. Australia Rare Kidney Diseases Treatment Market Size (2018-2029) & (US$ Million)
    Figure 50. Latin America Rare Kidney Diseases Treatment Market Share by Country (2018-2029)
    Figure 51. Mexico Rare Kidney Diseases Treatment Market Size (2018-2029) & (US$ Million)
    Figure 52. Brazil Rare Kidney Diseases Treatment Market Size (2018-2029) & (US$ Million)
    Figure 53. Middle East & Africa Rare Kidney Diseases Treatment Market Share by Country (2018-2029)
    Figure 54. Turkey Rare Kidney Diseases Treatment Market Size (2018-2029) & (US$ Million)
    Figure 55. Saudi Arabia Rare Kidney Diseases Treatment Market Size (2018-2029) & (US$ Million)
    Figure 56. UAE Rare Kidney Diseases Treatment Market Size (2018-2029) & (US$ Million)
    Figure 57. Bottom-up and Top-down Approaches for This Report

Global Rare Kidney Diseases Treatment market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Demand from Atypical Hemolytic Uremic Syndrome and Nephropathic Cystinosis are the major drivers for the industry.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Rare Kidney Diseases Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Companies, Type, Application and Regions Listed in the Report:
By Company
    Aurinia Pharmaceuticals
    Sanofi
    Calliditas Therapeutics AB
    Shire
    GSK
    Amicus Therapeutics
    Horizon Therapeutics
    Advicenne
    Reata Pharmaceuticals
    Alexion Pharmaceuticals
    Otsuka Pharmaceutical

Segment by Type
    Enzyme Replacement Therapy
    Monoclonal Antibodies
    Others

Segment by Application
    Atypical Hemolytic Uremic Syndrome
    Nephropathic Cystinosis
    Lupus Nephritis
    Others

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        
    Latin America
        Mexico
        Brazil
        
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

Each chapter of the report provides detailed information for readers to understand the Rare Kidney Diseases Treatment market further:
Chapter 1: Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029).
Chapter 2: Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3: Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4: Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Companies’ Outline, covering company’s basic information, Rare Kidney Diseases Treatment introduction, etc. Rare Kidney Diseases Treatment Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10: Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11: Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12: QYResearch’s Conclusions of Rare Kidney Diseases Treatment market based on comprehensive survey.
Chapter 13: Methodology and Data Sources adopted by QYResearch.